228 related articles for article (PubMed ID: 26577809)
21. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F
Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851
[TBL] [Abstract][Full Text] [Related]
22. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
[TBL] [Abstract][Full Text] [Related]
23. Hedgehog signaling through GLI1 and GLI2 is required for epithelial-mesenchymal transition in human trophoblasts.
Tang C; Mei L; Pan L; Xiong W; Zhu H; Ruan H; Zou C; Tang L; Iguchi T; Wu X
Biochim Biophys Acta; 2015 Jul; 1850(7):1438-48. PubMed ID: 25888497
[TBL] [Abstract][Full Text] [Related]
24. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.
Regl G; Kasper M; Schnidar H; Eichberger T; Neill GW; Philpott MP; Esterbauer H; Hauser-Kronberger C; Frischauf AM; Aberger F
Cancer Res; 2004 Nov; 64(21):7724-31. PubMed ID: 15520176
[TBL] [Abstract][Full Text] [Related]
25. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
26. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
27. Role of GLI2 in the growth of human osteosarcoma.
Nagao H; Ijiri K; Hirotsu M; Ishidou Y; Yamamoto T; Nagano S; Takizawa T; Nakashima K; Komiya S; Setoguchi T
J Pathol; 2011 Jun; 224(2):169-79. PubMed ID: 21506130
[TBL] [Abstract][Full Text] [Related]
28. Redundant and differential roles of transcription factors Gli1 and Gli2 in the development of mouse fetal Leydig cells.
Barsoum I; Yao HH
Biol Reprod; 2011 May; 84(5):894-9. PubMed ID: 21209421
[TBL] [Abstract][Full Text] [Related]
29. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals.
Katoh Y; Katoh M
Int J Oncol; 2009 Jul; 35(1):187-92. PubMed ID: 19513567
[TBL] [Abstract][Full Text] [Related]
30. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
32. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
34. ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression.
Tang C; Li L; Xu Q; Xu S; Lin C; Cao B
Mol Carcinog; 2023 Jun; 62(6):882-893. PubMed ID: 36988340
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
Kern D; Regl G; Hofbauer SW; Altenhofer P; Achatz G; Dlugosz A; Schnidar H; Greil R; Hartmann TN; Aberger F
Oncogene; 2015 Oct; 34(42):5341-51. PubMed ID: 25639866
[TBL] [Abstract][Full Text] [Related]
36. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer.
Wei L; Xu Z
Int J Cancer; 2011 Jul; 129(2):275-84. PubMed ID: 20839260
[TBL] [Abstract][Full Text] [Related]
37. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo.
Dennler S; André J; Alexaki I; Li A; Magnaldo T; ten Dijke P; Wang XJ; Verrecchia F; Mauviel A
Cancer Res; 2007 Jul; 67(14):6981-6. PubMed ID: 17638910
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
Makinodan E; Marneros AG
Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
[TBL] [Abstract][Full Text] [Related]
39. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling.
Riobó NA; Lu K; Ai X; Haines GM; Emerson CP
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4505-10. PubMed ID: 16537363
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
Porta C; Figlin RA
J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
